In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 27th, 2005 | 28 | Yes |
Popular Name: Prazosin Hydrochloride Prazosin Hydrochloride
Find On: PubMed — Wikipedia — Google
CAS Numbers: 19216-56-9 , 19216-56-9; 19237-84-4; 86126-06-9 , 19237-84-4 , 19237-84-4, 19216-56-9 [p , 19237-84-4, 19216-56-9 [prazosin] , [19237-84-4]
(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(furan-2-yl)methanone
1-(3-Amino-6,7-dimethoxy-2- quinazolinyl)-4-(2-furanyl-carbonyl)piperazine hydrochloride
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl) piperazine
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine
2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline
2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine
4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone
5-25-13-00365 (Beilstein Handbook Reference)
CP-12299; CP-122991; CP-12299-1
CPD000449301; Prazosin; SAM001246995
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)- (9CI)
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)- (8CI)
Quinazoline, 4-amino-6,7-dimethoxy-2-(4-(2-furoyl)piperazin-1-yl)-
[4-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-piperazin-1-yl]-furan-2-yl-methanone
[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.91 | 7.64 | -36.73 | 3 | 9 | 1 | 108 | 384.416 | 4 | ↓ |
Hi High (pH 8-9.5) | 1.91 | 7.26 | -15.54 | 2 | 9 | 0 | 107 | 383.408 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
mechanism | . | ZereneX Building Blocks |
MP | 285 | TCI |
mechanism | Alpha 2B -Adrenoceptor antagonist, | IBScreen Bioactives |
Therapy | antihypertensive | SMDC Iconix |
biological_use | Antihypertensive agent | IBScreen Bioactives |
Indications | antihypertensive, anxiety/panic | KeyOrganics Bioactives |
mechanism | Melatonin MT 3 -receptor antagonist | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 100730; .75 water; 1 hydrogen chloride | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 100730; SALT: .75 water; 1 hydrogen chloride | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
5HT1A-4-E | Serotonin 1a (5-HT1a) Receptor (cluster #4 Of 4), Eukaryotic | Eukaryotes | 2360 | 0.28 | Binding ≤ 10μM |
5HT1B-1-E | Serotonin 1b (5-HT1b) Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
5HT1D-1-E | Serotonin 1d (5-HT1d) Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
5HT2A-1-E | Serotonin 2a (5-HT2a) Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1500 | 0.29 | Binding ≤ 10μM |
AA3R-4-E | Adenosine Receptor A3 (cluster #4 Of 6), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
ADA1A-1-E | Alpha-1a Adrenergic Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
ADA1B-1-E | Alpha-1b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
ADA1D-1-E | Alpha-1d Adrenergic Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
ADA2A-1-E | Alpha-2a Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 106 | 0.35 | Binding ≤ 10μM |
ADA2B-1-E | Alpha-2b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 97 | 0.35 | Binding ≤ 10μM |
ADA2C-1-E | Alpha-2c Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 97 | 0.35 | Binding ≤ 10μM |
DRD4-4-E | Dopamine D4 Receptor (cluster #4 Of 4), Eukaryotic | Eukaryotes | 8300 | 0.25 | Binding ≤ 10μM |
KCNH2-1-E | HERG (cluster #1 Of 5), Eukaryotic | Eukaryotes | 1585 | 0.29 | Binding ≤ 10μM |
MT3-1-E | Metallothionein-3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8 | 0.40 | Binding ≤ 10μM |
OPRM-1-E | Mu-type Opioid Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
S22A1-1-E | Solute Carrier Family 22 Member 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9900 | 0.25 | Binding ≤ 10μM |
Z104304-1-O | Adrenergic Receptor Alpha-1 (cluster #1 Of 3), Other | Other | 1 | 0.45 | Binding ≤ 10μM |
Z50597-5-O | Rattus Norvegicus (cluster #5 Of 5), Other | Other | 3000 | 0.28 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 5012 | 0.26 | Functional ≤ 10μM |
Z50597-1-O | Rattus Norvegicus (cluster #1 Of 12), Other | Other | 0 | 0.00 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AA3R_HUMAN | P33765 | Adenosine A3 Receptor, Human | 0.86 | 0.45 | Binding ≤ 1μM |
Z104304 | Z104304 | Adrenergic Receptor Alpha-1 | 0.1 | 0.50 | Binding ≤ 1μM |
ADA1A_RAT | P43140 | Alpha-1a Adrenergic Receptor, Rat | 0.254 | 0.48 | Binding ≤ 1μM |
ADA1A_HUMAN | P35348 | Alpha-1a Adrenergic Receptor, Human | 0.27 | 0.48 | Binding ≤ 1μM |
ADA1A_BOVIN | P18130 | Alpha-1a Adrenergic Receptor, Bovin | 0.17 | 0.49 | Binding ≤ 1μM |
ADA1B_RAT | P15823 | Alpha-1b Adrenergic Receptor, Rat | 0.19 | 0.49 | Binding ≤ 1μM |
ADA1B_HUMAN | P35368 | Alpha-1b Adrenergic Receptor, Human | 0.21 | 0.48 | Binding ≤ 1μM |
ADA1B_MESAU | P18841 | Alpha-1b Adrenergic Receptor, Mesau | 0.83 | 0.45 | Binding ≤ 1μM |
ADA1D_HUMAN | P25100 | Alpha-1d Adrenergic Receptor, Human | 0.2 | 0.48 | Binding ≤ 1μM |
ADA1D_RAT | P23944 | Alpha-1d Adrenergic Receptor, Rat | 0.2 | 0.48 | Binding ≤ 1μM |
ADA2A_BOVIN | Q28838 | Alpha-2a Adrenergic Receptor, Bovin | 106 | 0.35 | Binding ≤ 1μM |
ADA2A_HUMAN | P08913 | Alpha-2a Adrenergic Receptor, Human | 108 | 0.35 | Binding ≤ 1μM |
ADA2A_MOUSE | Q01338 | Alpha-2a Adrenergic Receptor, Mouse | 13 | 0.39 | Binding ≤ 1μM |
ADA2A_RAT | P22909 | Alpha-2a Adrenergic Receptor, Rat | 0.4 | 0.47 | Binding ≤ 1μM |
ADA2B_RAT | P19328 | Alpha-2b Adrenergic Receptor, Rat | 0.4 | 0.47 | Binding ≤ 1μM |
ADA2B_MOUSE | P30545 | Alpha-2b Adrenergic Receptor, Mouse | 13 | 0.39 | Binding ≤ 1μM |
ADA2B_HUMAN | P18089 | Alpha-2b Adrenergic Receptor, Human | 108 | 0.35 | Binding ≤ 1μM |
ADA2C_MOUSE | Q01337 | Alpha-2c Adrenergic Receptor, Mouse | 13 | 0.39 | Binding ≤ 1μM |
ADA2C_RAT | P22086 | Alpha-2c Adrenergic Receptor, Rat | 0.4 | 0.47 | Binding ≤ 1μM |
ADA2C_HUMAN | P18825 | Alpha-2c Adrenergic Receptor, Human | 108 | 0.35 | Binding ≤ 1μM |
MT3_HUMAN | P25713 | Metallothionein-3, Human | 7.8 | 0.41 | Binding ≤ 1μM |
OPRM_RAT | P33535 | Mu Opioid Receptor, Rat | 0.2 | 0.48 | Binding ≤ 1μM |
5HT1B_HUMAN | P28222 | Serotonin 1b (5-HT1b) Receptor, Human | 0.55 | 0.46 | Binding ≤ 1μM |
5HT1D_HUMAN | P28221 | Serotonin 1d (5-HT1d) Receptor, Human | 0.33 | 0.47 | Binding ≤ 1μM |
AA3R_HUMAN | P33765 | Adenosine A3 Receptor, Human | 0.86 | 0.45 | Binding ≤ 10μM |
Z104304 | Z104304 | Adrenergic Receptor Alpha-1 | 0.1 | 0.50 | Binding ≤ 10μM |
ADA1A_HUMAN | P35348 | Alpha-1a Adrenergic Receptor, Human | 0.27 | 0.48 | Binding ≤ 10μM |
ADA1A_BOVIN | P18130 | Alpha-1a Adrenergic Receptor, Bovin | 0.17 | 0.49 | Binding ≤ 10μM |
ADA1A_RAT | P43140 | Alpha-1a Adrenergic Receptor, Rat | 0.254 | 0.48 | Binding ≤ 10μM |
ADA1B_MESAU | P18841 | Alpha-1b Adrenergic Receptor, Mesau | 0.83 | 0.45 | Binding ≤ 10μM |
ADA1B_RAT | P15823 | Alpha-1b Adrenergic Receptor, Rat | 0.19 | 0.49 | Binding ≤ 10μM |
ADA1B_HUMAN | P35368 | Alpha-1b Adrenergic Receptor, Human | 0.21 | 0.48 | Binding ≤ 10μM |
ADA1D_HUMAN | P25100 | Alpha-1d Adrenergic Receptor, Human | 0.2 | 0.48 | Binding ≤ 10μM |
ADA1D_RAT | P23944 | Alpha-1d Adrenergic Receptor, Rat | 0.2 | 0.48 | Binding ≤ 10μM |
ADA2A_PIG | P18871 | Alpha-2a Adrenergic Receptor, Pig | 4100 | 0.27 | Binding ≤ 10μM |
ADA2A_BOVIN | Q28838 | Alpha-2a Adrenergic Receptor, Bovin | 106 | 0.35 | Binding ≤ 10μM |
ADA2A_MOUSE | Q01338 | Alpha-2a Adrenergic Receptor, Mouse | 13 | 0.39 | Binding ≤ 10μM |
ADA2A_RAT | P22909 | Alpha-2a Adrenergic Receptor, Rat | 0.4 | 0.47 | Binding ≤ 10μM |
ADA2A_HUMAN | P08913 | Alpha-2a Adrenergic Receptor, Human | 108 | 0.35 | Binding ≤ 10μM |
ADA2B_RAT | P19328 | Alpha-2b Adrenergic Receptor, Rat | 0.4 | 0.47 | Binding ≤ 10μM |
ADA2B_MOUSE | P30545 | Alpha-2b Adrenergic Receptor, Mouse | 13 | 0.39 | Binding ≤ 10μM |
ADA2B_HUMAN | P18089 | Alpha-2b Adrenergic Receptor, Human | 108 | 0.35 | Binding ≤ 10μM |
ADA2C_HUMAN | P18825 | Alpha-2c Adrenergic Receptor, Human | 108 | 0.35 | Binding ≤ 10μM |
ADA2C_MOUSE | Q01337 | Alpha-2c Adrenergic Receptor, Mouse | 13 | 0.39 | Binding ≤ 10μM |
ADA2C_RAT | P22086 | Alpha-2c Adrenergic Receptor, Rat | 0.4 | 0.47 | Binding ≤ 10μM |
DRD4_HUMAN | P21917 | Dopamine D4 Receptor, Human | 8300 | 0.25 | Binding ≤ 10μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 1584.89319 | 0.29 | Binding ≤ 10μM |
MT3_HUMAN | P25713 | Metallothionein-3, Human | 7.8 | 0.41 | Binding ≤ 10μM |
OPRM_RAT | P33535 | Mu Opioid Receptor, Rat | 0.2 | 0.48 | Binding ≤ 10μM |
Z50597 | Z50597 | Rattus Norvegicus | 3000 | 0.28 | Binding ≤ 10μM |
5HT1A_RAT | P19327 | Serotonin 1a (5-HT1a) Receptor, Rat | 2360 | 0.28 | Binding ≤ 10μM |
5HT1B_HUMAN | P28222 | Serotonin 1b (5-HT1b) Receptor, Human | 0.55 | 0.46 | Binding ≤ 10μM |
5HT1D_HUMAN | P28221 | Serotonin 1d (5-HT1d) Receptor, Human | 0.33 | 0.47 | Binding ≤ 10μM |
5HT2A_RAT | P14842 | Serotonin 2a (5-HT2a) Receptor, Rat | 1500 | 0.29 | Binding ≤ 10μM |
S22A1_HUMAN | O15245 | Solute Carrier Family 22 Member 1, Human | 9900 | 0.25 | Binding ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 10000 | 0.25 | Functional ≤ 10μM |
Z50597 | Z50597 | Rattus Norvegicus | 0.13 | 0.49 | Functional ≤ 10μM |
Description | Species |
---|---|
Abacavir transmembrane transport | |
Adenosine P1 receptors | |
Adrenaline signalling through Alpha-2 adrenergic receptor | |
Adrenaline,noradrenaline inhibits insulin secretion | |
Adrenoceptors | |
Dopamine receptors | |
G alpha (12/13) signalling events | |
G alpha (i) signalling events | |
G alpha (q) signalling events | |
G alpha (z) signalling events | |
G-protein activation | |
Na+/Cl- dependent neurotransmitter transporters | |
Neurotransmitter Clearance In The Synaptic Cleft | |
Norepinephrine Neurotransmitter Release Cycle | |
Opioid Signalling | |
Organic cation transport | |
Peptide ligand-binding receptors | |
Serotonin receptors | |
Voltage gated Potassium channels |